▲ Peaking
Business
Eli Lilly Leads 5 Stocks Near Buy Points As The Market Rally Rotates
Eli Lilly's stock surges following regulatory approvals and market rally.
2 trends tracked about this subject — the full history, oldest to newest below.
Eli Lilly's stock surges following regulatory approvals and market rally.
Eli Lilly's Jaypirca has received a positive CHMP recommendation for the treatment of chronic lymphocytic leukemia (CLL) in the European Union.